Trump's Secret Stocks: Revealed
The Office of Bonner Private Research are closed for the Christmas holiday. While we’re away, we’ve arranged to publish some essays on the investment landscape for 2025 from some of our friends. Below you, you’ll find part three of a three part series. Merry Christmas and Happy Holidays!
Dear Reader,
We’re deep into the rabbit hole.
Gold, Bitcoin, Franco-Nevada, Microstrategy… As we’ve discussed in the prior two emails, they’re all “Trump trades” that are set to profit after the presidential inauguration. Especially in the case of Franco-Nevada and Microstrategy, they may be assets you’ve never thought about buying until now.
If you haven’t, though, you should.
Each one offers significant upside potential while – with the exception of MicroStrategy – also protecting your wealth from the ongoing inflation and money printing I see as inevitable during Trump’s next term.
But we still have farther to go.
When it comes to real, life-changing money…
There are six secret Trump stocks you need to know about. These are the little-known companies connected to, or owned by, Trump insiders and backers.
When I visited Mar-a-Lago for a strategy meeting last March, I was there to figure out how cutting regulations and getting rid of government-propped-up zombie businesses could unleash real American capitalism – and enrich a lot of great Americans in the process.
I learned a lot while I was there... and I want to share some of that knowledge with you.
I spent most of the afternoon and worked well into the evening with the Trump insider who’d invited me. My wife then joined us for dinner in Mar-a-Lago’s stadium-like outdoor dining room – the whole place cheered when Trump’s plane flew directly over the club just before dark.
And the next morning we met briefly with Trump as he was leaving to play a round of golf. I assured the future president that we had a great plan. And that we would do our part to make America great again.
Trump’s secret stocks are a direct beneficiary of that agenda.
As I learned through my connections, Trump insiders are already loading up on these stocks – often, to the tune of millions of dollars.
Whether it’s the Department of Government Efficiency…his promise of sweeping deregulation… RFK Junior’s plan to Make America Healthy Again…
Or the unshackling of America’s energy sector… the embracing of cryptocurrency and artificial intelligence… or the dismantling of the bureaucratic deep state…
Each of Trump’s major policy platforms offers a unique investment idea.
They include...
· The “abandoned” oil field off the shores of California that one of Trump’s biggest, yet most reclusive, backers is dumping all of his money into… even going so far as to sell his private plane so he could raise more capital to invest in this left-for-dead asset..
· The biotech company that could be one of the biggest beneficiaries of Elon Musk’s Department of Government Efficiency...
· The “Make America Healthy Again” drinks company that’s owned by some of Trump’s richest Wall Street backers, like AQR, Citadel, and Millennium...
Plus three more that you (and 99.9% of American investors) likely haven’t heard of... yet.
Like the disruptor America needs to fix its undeniably broken healthcare system…
A health insurance company Americans love more than AAPL
This business is a health insurance company co-founded in 2012 by former MIT scientist Mario Schlosser and venture capitalist Joshua Kushner, brother of Jared Kushner (Donald Trump's son-in-law and first-term Trump administration advisor).
The company’s mission is to disrupt the American healthcare status quo, using technology to offer more affordable health insurance while also delivering better patient outcomes. Specifically, the company aims to address two of the biggest problems plaguing America’s broken health care system.
The first problem is that 97% of U.S. physicians, hospitals, and other healthcare providers operate a fee-based business model. This creates an incentive for providers to earn more money by charging higher prices, and also by encouraging excessive consumption of services, regardless of patient outcomes. As a result, healthcare costs have increased at rates well above the overall pace of inflation for decades:
The second problem is that, as a result of the runaway costs of medical care, insurance companies that pay for this care must raise premiums and must rein in their costs by denying coverage. This includes companies like UnitedHealth Group (UNH), which has a denial rate of 32%.
As a result, health insurance has become one of the most universally reviled industries in America, and the U.S. has some of the worst health outcomes of the developed world, despite spending the most of any country on a per-capita basis, at 18% of GDP.
Government healthcare spending on programs like Medicare and Medicaid currently make up the single largest line item in the federal budget, at $1.6 trillion per year, or 28% of all government spending, providing the incoming Trump administration a great opportunity to cut the U.S. budget deficit:
This company’s business model, however, offers a solution to the broken fee-based healthcare model in the form of a newer model known as value-based care. In this system, healthcare providers like doctors and hospitals partner with insurance companies to share in the risk and the profitability of delivering healthcare. This includes structuring the payment terms from insurance companies to providers in a way that is linked to overall patient outcomes and to the cost effectiveness of the care provided. In this way, value-based care aligns incentives toward the ultimate end goal of delivering the best patient outcomes at the lowest cost.
The ease of use of its platform, low rate of premium inflation, and low rate of claim denials have made this business one of the rare healthcare companies that customers love. We can quantify this using the net promoter score (“NPS”), a numerical rating system that measures the likelihood of customers recommending a company’s product or service on a scale of -100 to +100.
Overall, U.S. health insurance companies as an industry have an average NPS score in the low single digits, with many of America’s largest insurers deeply in the negative. Oscar, on the other hand, sports an NPS score of 66. This puts the company in the same league as many of America’s most beloved brands like Netflix (NFLX), with an NPS of 67, and Apple (AAPL) with a score of 61.
But the ultimate proof of the company’s success shows up in its rapid growth rate since inception. Since its founding in 2012, the company has grown its customer count from zero to 1.7 million members (compared with 50 million for UnitedHealth and more than 100 million for Blue Cross Blue Shield). And this growth shows no signs of slowing, with membership increasing at a 42% compounded annual growth rate (“CAGR”) over the last three years. The company is on the cusp of reaching sustained profitability, with management setting a goal of achieving $2.25 in earnings per share by 2027.
Given the company’s healthy growth rate, we believe a fair valuation multiple would be roughly 25x earnings. That would translate into a price target of $56 per share by 2027, or a 300% return from its current price of $14.
With the incoming Trump administration facing one of the largest budget deficits on record, this company could become one of the biggest winners by helping solve America’s runaway healthcare spending.
We’re not the only ones seeing this opportunity. The company’s single largest shareholder is Thrive Capital, an investment fund owned by Oscar co-founder, Josh Kushner. In the days following Trump’s presidential victory, Thrive bought 3.5 million shares worth $50 million in a series of open market purchases at prices ranging from $13 to $17 per share.
We also have the details on a company that offers you the chance to profit from Trump’s top dealmaker… who I call “The Man Behind the Curtain.”
The art of the deal
Most Americans have never heard of this reclusive billionaire financier – but we believe his company could be among the biggest beneficiaries of Trump’s second term.
His company has lent hundreds of millions of dollars to entities within Trump’s orbit, and the financier himself personally donated millions to Trump’s presidential campaign. Additionally, Trump has appointed members of the company’s board to key positions., such as Jay Clayton – a former chair of the U.S. Securities and Exchange Commission – who was recently appointed as U.S. Attorney for the Southern District of New York, known for prosecuting financial crimes. And Trump’s admiration for this billionaire’s business acumen and alignment with his policies – such as support for Israel – further solidify this relationship.
Reports suggest the financier was previously in the running to be nominated as Trump’s Treasury Secretary, a position which ultimately went to former hedge-fund manager Scott Bessent. But make no mistake, he’s likely to be one of the most powerful figures influencing America’s financial and economic landscape under the new administration.
The Man Behind the Curtain has steered his company to tremendous growth despite the anti-business environment of the past few years. Under his guidance, revenue has grown more than 500% since 2021, while earnings have grown by over 300%. The company is currently producing a healthy free cash flow margin of 19%, and generates a highly-efficient return on invested capital above 20%.
It’s also worth noting that he personally owns 34 million shares in the company, or roughly 6% of the amount outstanding. Unlike many CEOs, he has substantial skin in the game, meaning his interests are heavily aligned with those of shareholders.
The stock is up nearly more than 300% over the past three years – including 90% over the past year alone – and doesn’t appear cheap at 20x earnings and 6x book value (up from a prior range of 4-5x). However, we believe Wall Street is underestimating this billionaire’s prowess.
As the Man Behind the Curtain leverages his political connections and influence, the deals he’s able to structure… the regulations he’s able to “circumvent”... and the levers he’s able to pull… could allow his firm to grow even faster than it has since he took the helm in 2021. Add on a reasonable valuation premium for this growth, and this stock could easily return 500% or more over the next four years.
What’s next for these (and more) Trump stocks
These are all investment ideas with immense upside from Trump’s second term… companies with potential returns of 1,000% or more. Companies with the potential to transform your financial future… if you get in now before they go mainstream.
Yet, as far as I know, nobody in either the mainstream or independent financial media is shining the spotlight on these companies and urging Americans to buy.
Not because of any grand conspiracy to keep you in the dark but simply because they don’t know about them. But I do. And I’m exposing them now for the first time... to a select group of readers.
Each of these “secret stocks”…
The ones Trump insiders are loading up on…
The ones Trump connections own, support, and will lobby for…
I’ve analyzed them all in exhaustive, exacting detail inside my brand-new investment briefing…
Click here to learn how to get it.
Everything we’ve touched on today is explored in far greater detail…
… including a full analysis of the 6 Secret Trump Stocks that we believe could potentially make early investors a killing over the next four years…
… and as you can see, this isn’t some flimsy 12-page report that other firms attempt to pass off as legitimate investment research.
The analysis we publish here at Porter & Co. is on par with the research produced by some of Wall Street’s top institutions – the type of insights that banks and hedge funds often pay $20,000+ to access.
The only difference is that we don’t serve Wall Street… We serve you and tens of thousands of hardworking Americans just like you who want to grow their wealth safely.
Our mission is to level the playing field so that you can get the same investment insights that have typically been reserved for professional investors.
And Trump’s Secret Stocks may be one of the most valuable and urgent projects my team has ever produced, one that I believe has the potential to transform thousands of people's lives.
I look forward to sharing this privileged information with you.
Just click here to watch my full briefing – and learn how to download Trump’s Secret Stocks right now.
To your success,
Porter Stansberry